TMates GLP-1

Product Details

TMates lists semaglutide as a weight-loss treatment and describes the program as including provider review, personalized dosing, medication, and ongoing support. The weight-loss category identifies Semaglutide as an injectable treatment starting from $158 per month on the longest plan.

What Is TMates GLP-1?

TMates GLP-1 refers to the company’s semaglutide-based weight-management offering. Semaglutide belongs to the GLP-1 receptor agonist class and is presented by TMates as a prescription medication intended to support appetite regulation, healthier eating habits, feelings of fullness, and weight-management goals. It is provided through a structured telemedicine program rather than as a conventional dietary supplement.

The program is available in an injectable format, with an oral option also available. TMates describes the treatment as provider-supervised, with dosing selected according to individual circumstances, health information, and medical eligibility. The program also includes ongoing support to help individuals follow their prescribed weight-management plan.

Who May Consider TMates GLP-1?

Adults seeking a medically supervised approach to weight management may consider discussing a semaglutide program with a qualified healthcare provider. TMates uses an online health-history and goals intake before a licensed medical provider determines eligibility.

The program may be relevant for adults looking for prescription-based appetite and weight-management support rather than a conventional dietary supplement. Anyone experiencing unexplained weight changes or ongoing symptoms should obtain appropriate professional medical evaluation.

How May TMates GLP-1 Support General Wellness?

Semaglutide is a GLP-1 receptor agonist. TMates describes its semaglutide program as supporting appetite and craving regulation, healthier eating habits, feelings of fullness, and weight-management goals.

The product page explains that semaglutide can slow digestion and increase feelings of fullness. These descriptions concern the medication’s intended pharmacological effects and should not be interpreted as a guarantee of a particular weight-loss result.

TMates reports that some patients have lost up to 15% of body weight in a year or less, while also noting that results depend on starting weight and other factors. Individual results can differ.

Active Ingredients

The following section covers the active medication rather than dietary-supplement ingredients.

Semaglutide

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in prescription weight-management programs. It works on GLP-1 receptors involved in appetite regulation, helping support feelings of fullness and reduced food intake. TMates offers several displayed dosage levels, including 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, with the appropriate dose determined through provider assessment. The product is presented as part of a medically supervised weight-management program that includes personalized dosing and ongoing support.

Potential Benefits

• Support appetite regulation as part of a structured approach to weight management and healthier lifestyle habits.
• Support healthier eating habits by helping manage appetite and food cravings as part of a weight-management plan.
• Increase feelings of fullness during and after meals, which may support more mindful eating patterns.
• Provides a prescription GLP-1 medication option for adults seeking medically supervised support for weight-management goals.
• Includes personalized dosing and ongoing support through TMates’ provider-guided telemedicine weight-management program.

TMates presents these functions as part of its weight-management program rather than as guaranteed outcomes.

Important Limitations

• The public product page does not provide a conventional Supplement Facts panel.
• Individual dosing is determined through medical review rather than a fixed supplement serving.
• The specific dispensing pharmacy and complete inactive-ingredient list are not publicly disclosed on the product page.
• Compounded semaglutide is not FDA-approved and does not undergo FDA premarket review for safety, effectiveness, or quality.

How to Use?

TMates GLP-1 comes in an injectable form, with an oral option also available on the product page.

• Use the medication according to the individualized prescription and dosing instructions supplied by the prescribing provider.
• TMates displays injectable dosage levels of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg.
• The injectable option is presented as a once-weekly treatment.
• If a dose is missed, TMates advises resuming the next scheduled dose rather than doubling up.
• Follow the dispensing pharmacy’s specific storage, handling, administration, and disposal instructions.

Because compounded injectable semaglutide can be supplied at different concentrations, patients should use the exact measurement instructions supplied with their prescription and should not independently convert milligrams, milliliters, or syringe units.

Warnings and Precautions

• Use should follow an evaluation and prescription from an appropriately licensed healthcare provider.
• Discuss current prescription and nonprescription medicines with your healthcare provider before starting treatment.
• Tell your provider about existing medical conditions, previous medication reactions, and relevant medical history.
• Pregnancy and plans for pregnancy should be discussed with a healthcare professional before treatment.
• Breastfeeding should be discussed with a healthcare professional before use.
• Tell healthcare professionals about semaglutide use before planned surgery or procedures.
• Do not use medication from damaged packaging or without appropriate administration instructions.
• Keep medication according to the dispensing pharmacy’s storage instructions and away from children.
• Seek prompt medical attention for serious or unexpected reactions.

FDA has specifically highlighted dosing concerns with compounded injectable semaglutide, including errors involving different concentrations and confusion between milligrams, milliliters, and syringe units.

Possible Side Effects and Interactions

TMates lists nausea, mild injection-site reactions, decreased appetite, and possible gastrointestinal discomfort among potential effects. Semaglutide medicines can also be associated with gastrointestinal reactions and other clinically important effects. People taking other medications should discuss potential interactions with a healthcare professional, particularly because semaglutide can affect gastric emptying.

Pros

• Prescription weight-management option: Available through TMates’ online telemedicine program with provider assessment.
• Personalized dosing: Dosage is determined based on individual needs and provider evaluation.
• Multiple formats: Injectable and oral options are displayed for added treatment flexibility.
• Ongoing program support: The listed plans include medication along with continued support throughout the program.
• Flexible program durations: One-, three-, six-, and twelve-month options are available, with lower monthly costs on longer plans.

Cons

• Product-specific inactive ingredients are not publicly disclosed.
• The dispensing pharmacy is not identified on the public product page.
• A conventional Supplement Facts panel is not applicable because this is a prescription medication.
• Compounded medication is not FDA-approved.

Pricing Options

TMates currently offers several program durations, with medication and ongoing support included in the listed pricing.

Pricing and availability were checked on August 24, 2026 and may change on the official website.

Pharmacist Note

Semaglutide is a prescription medication rather than a dietary supplement. Before use, review the prescribed dose, administration instructions, other medications, medical history, and any pregnancy or surgical considerations with your healthcare professional. Use the exact pharmacy-provided instructions for administration and storage.

Frequently Asked Questions

1. What type of product is TMates GLP-1?

TMates GLP-1 is a prescription semaglutide weight-management medication provided through a medically supervised telemedicine program.

2. How should TMates GLP-1 be taken?

The injectable option is presented as once weekly, with the exact dose and administration instructions determined by the prescribing provider.

3. How long does one program last?

TMates offers one-, three-, six-, and twelve-month program options, depending on the plan selected at checkout.

4. Can it be taken with prescription medication?

Discuss all prescription medications with your healthcare provider because semaglutide may affect gastric emptying and medication absorption.

5. Is it suitable during pregnancy or breastfeeding?

Pregnancy and breastfeeding require individualized medical guidance; discuss semaglutide use with a qualified healthcare professional before treatment.

6. Where can TMates GLP-1 be purchased?

TMates provides the treatment through its online telemedicine platform after medical review determines eligibility for treatment.

7. Does it contain common allergens?

The public product page does not provide a complete inactive-ingredient or allergen list for the specific compounded medication.

8. What is the refund period?

A specific money-back guarantee or refund period is not publicly disclosed on the current Semaglutide product page.

Medical Disclaimer

“These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Consult a qualified healthcare professional before using a dietary supplement, particularly if you are pregnant, breastfeeding, taking medication or managing a medical condition.”

Sources and Product Review Information

• Official product page: TMates Semaglutide product information, dosage options, program inclusions, pricing, administration information, and FAQs.
• Weight Loss category: TMates Weight Loss category and current Semaglutide starting price.
• TMates How It Works: Information concerning telemedicine consultations, provider assessment, coaching, medication, and personalized treatment.
• FDA: Safety information concerning compounded semaglutide, dosing errors, concentration differences, and FDA review status.
• FDA/DailyMed: Semaglutide safety, adverse-effect, interaction, and precaution information used for general medication context.
• Product information checked: August 24, 2026.

Affiliate Disclosure: This page may contain affiliate links. If you make a purchase through one of these links, we may earn a commission at no additional cost to you. This does not influence the information presented above, which is based on publicly available product and label information.